RxDoctor Payments DataLook up a doctor →

Robert Ferrera, MD

Adult Medicine · Sacramento, CANPI 1578718938

Payments from drug & device makers

$2,619,888in general payments, 2019–2025

Across 676 payments — averaging $3875.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$1.1M
  • Modernatx, Inc.$1M
  • GSK$301K
  • Novavax Inc$169K
  • Astrazeneca UK Limited$35K
  • AbbVie$2K
  • plus $435 from 2 others

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Pfizer42$1,080,188
Modernatx, Inc.533$1,032,523
GSK37$300,705
Novavax Inc24$169,044
Astrazeneca UK Limited2$34,654
AbbVie(2 entities)35$2,338
Merz North America, Inc.2$386
Galderma Laboratories, L.p.1$49

How this compares

$2,619,888 in reported general payments places this provider in the 95th percentile of 221 adult medicine providers in California.

See all adult medicine providers in California

Medicare billing

Part B allowed, 2024
$68,278
Medicare patients
125
Services billed
755

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other adult medicine in Sacramento

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →